Suggestions
Mark McDade
Qiming Venture Partners USA
Mark McDade is a seasoned professional with over 30 years of experience in private and public healthcare and life science companies. He co-founded Qiming Venture Partners USA in January 2017 and previously held key executive roles at prominent organizations.
Prior to his role at Qiming, Mark served as the Executive Vice President and Chief Operating Officer at UCB, a global biopharmaceutical company based in Brussels, Belgium. His leadership skills and industry knowledge have played a vital role in his successful career.
Mark's diverse experience includes serving as the CEO of PDL Biopharma, CEO of Signature BioScience, and as a co-founder and COO at Corixa Corporation. He also held significant roles at Boehringer Mannheim Therapeutics and Sandoz Ltd. before embarking on his journey with Qiming Venture Partners USA.
With a strong educational background, Mark obtained a B.A. from Dartmouth College and an M.B.A. from Harvard Business School, further enhancing his business acumen and strategic decision-making capabilities.
Currently, Mark McDade leverages his vast expertise by serving on the boards of various companies within Qiming's portfolio. He has been actively involved in the growth and success of organizations such as Icosavax, Aimmune Therapeutics, Dermira Inc., and Lupin Ltd. His contributions as a director have been instrumental in shaping the direction of these companies.
Recognized for his industry insights and leadership skills, Mark McDade continues to make a significant impact in the biopharmaceutical and healthcare sectors. His tenure at renowned companies and his dedication to advancing innovation and growth highlight his commitment to excellence.